Special thanks to Progenics for making this webinar series possible.
The information presented on this webinar is for educational purposes only and should not substitute the advice of your doctor(s) and medical team because they have in depth knowledge of your medical history and current situation.
Questions & timing are below:
Q 1 at 33:31 Is Cu-64 DOTATATE imaging as sensitive as Ga-68? Is there a reason to consider one over the other?
Q 2 at 34:08 With SDHB genetic mutation, should this procedure be conducted periodically?
Q 3 at 35:30 What are consensus guidelines for imaging requirements post paraganglioma/pheochromocytoma excision?
Q 4 at 37:50 How often should I have a pet scan?
Q 5 at 41:03 Can DOTATATE PET scan identify metastasis in the liver? What is the best image modality for the diagnosis?
Q 6 at 42:26 What type of scan should be done for very small paragangliomas in the biliary system
Q 7 at 44:43 Do non-secreting tumors always show up in scans? When they are in the lungs is there a certain scan that works better than others?
Q 8 at 48:12 I have a 21-month-old son. What are the safety precautions with proximity/isolation, and for how long?
Q 9 at 49:24 Can tumor be not detected in the scan when it is not secreting?
Q 10 at 49:57 Is it possible that there are pheos/paras that give symptoms but cannot be detected by current scans, e.g. they have not yet discovered receptors?
Q 11at 56:33 What’s the minimal size of a tumor which can be detected by Ga-68 DOTATATE scan?
Q 12 at 57:25 Do we know what is the percentage of pheos/paras with somatostatin receptors?
Q 13 at 57:44 If you have light up in your spine should you get an MRI or the PET scan?